GATE 2026 exams span four days with forenoon and afternoon sessions. The exam covers engineering, science, arts, and ...
Zacks Investment Research on MSN
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates
Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $1.14 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to a loss of $1.5 per share a year ago. These ...
University of Michigan Interim President Domenico Grasso announced the five-year investment during his Nov. 13 State of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback